Dr. Jae Park

Dr. Jae Park, MD, is a hematologist-oncologist specializing in the care of patients with leukemia at Memorial Sloan Kettering Cancer Center, where he is a member of the Leukemia Service. He is dedicated to providing personalized, compassionate care, approaching each patient's treatment with the same attentiveness he would offer a member of his own family. His clinical expertise centers on acute and chronic lymphoid leukemias, with a commitment to individualized therapy tailored to each patient's unique circumstances.

As an active translational investigator, Dr. Park works across both the laboratory and clinical settings to bring innovative treatments to patients with leukemia. He serves as the lead investigator of a clinical trial using genetically modified T cells to treat patients with chronic lymphocytic leukemia (CLL), and is a co-principal investigator on several additional clinical trials focused on acute lymphoblastic leukemia (ALL) and CLL. His research reflects a sustained effort to develop more effective, targeted therapies by bridging scientific discovery with direct patient care.

Dr. Park's overarching goal as a physician is to develop new and potentially curative therapies for leukemia while maintaining a strong focus on compassionate, individualized care. He remains committed to addressing the full scope of each patient's needs throughout their treatment journey, combining scientific rigor with a deeply personal approach to oncology practice.